Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (statins) ameliorate atherosclerotic diseases. Macrophages play an important role in the development and subsequent stability of atherosclerotic plaques. We previously reported that oxidized low-density lipoprotein (Ox-LDL) induced macrophage proliferation through the secretion of granulocyte/macrophage colony-stimulating factor (GM-CSF) and consequent activation of p38 MAPK. The present study was designed to elucidate the mechanism of the inhibitory effect of statins on macrophage proliferation. Mouse peritoneal macrophages were used in our study. Cerivastatin and simvastatin each inhibited Ox-LDL-induced (Word count = 232)
Introduction
Immunohistochemical and pathological studies have established that foam cells observed in the early phase of atherosclerotic lesions are derived from blood monocytes/macrophages (1) (2) (3) . Macrophages take up oxidized low-density lipoprotein (Ox-LDL) through the scavenger receptor pathways and transform into foam cells in vitro (1) . These cells in turn produce various bioactive molecules, such as growth factors and cytokines, which play an important role in the progression of early-stage atherosclerotic process (4) . Previous in vivo studies reported that macrophages and macrophage-derived foam cells proliferated in atherosclerotic lesions (1) (2) (3) . On the other hand, macrophages also play an important role in the development and subsequent stability of atherosclerotic plaques (5) . In this regard, Aikawa et al. (6) demonstrated the proliferation and activation of macrophages in the atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits. Therefore, the proliferation of macrophages may be involved in both the development of early-phase of atherosclerotic lesions and the stability of atherosclerotic plaques.
We (7, 8) and other groups (9, 10) have shown that Ox-LDL enhances macrophage proliferation and survival in vitro. In addition, our previous study revealed that Ox-LDL could induce a rise in intracellular calcium concentration and subsequent activation of protein kinase C (PKC) in mouse peritoneal macrophages (8) . PKC activation mediates production of granulocyte/macrophage colony stimulating factor (GM-CSF), which plays a priming role in the Ox-LDL-induced macrophage proliferation (11) . Furthermore, p38 mitogen activated protein kinase (p38 MAPK)-dependent phosphatidylinositol-3 kinase (PI-3K) activation is involved, at least in part, downstream in the signaling pathway(s) after GM-CSF production (12) . However, the mechanism(s) of p38 MAPK activation through GM-CSF receptor is not clearly understood.
Seikagaku Corp., Japan). We confirmed that proliferation and viability of mouse resident macrophages was not affected by endotoxin at a concentration < 1 ng/ml under our experimental conditions.
Cell Culture
The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Kumamoto University. Peritoneal macrophages were collected from anesthetized male C3H/He mice (25-30 g ) by peritoneal lavage with 8 ml of ice-cold PBS, centrifuged at 200 × g for 5 min and suspended in RPMI 1640 medium (Nissui Seiyaku Co., Tokyo) supplemented with 10% heat-inactivated fetal calf serum (Life Technologies, Inc., Rockville, MD), streptomycin (0.1 mg/ml), and penicillin (100 units/ml) (medium A) (22) .
Cell suspensions were incubated in appropriate tissue culture plates for 90 min with medium A. More than 98% of adherent cells were considered to be macrophages based on four criteria, as described previously (23, 24) .
Adenoviral Vectors
Mouse peritoneal macrophages were infected with a recombinant replication-deficient adenovirus containing each of the genes of dominant negative Ras (Asn 17 -H-Ras), dominant negative RhoA (N 19 -RhoA) and dominant negative p38 MAPK at a multiplicity of infection (MOI) of approximately 50, as described previously (25) (26) (27) , and allowed to recover in medium A for 3 h. This condition conferred expression of LacZ as a marker gene in nearly 100% of transfected cells (25) . Triton X-100, and naphthol blue-black-stained nuclei were counted in a hemocytometer, as described previously (11) .
Enzyme-Linked Immunosorbent Assay (ELISA) for GM-CSF
Macrophage monolayers (2 × 10 6 cells/well in 6-well plate, Nunc) were cultured in 2 ml of medium A with or without the indicated effectors. After incubation for 4 h, 300 L of the medium were collected and immediately centrifuged at 10,000 × g for 1 min to remove any particulate material. The concentration of GM-CSF protein was determined as described previously (11) .
Quantitative PCR Analysis for GM-CSF mRNA
Macrophages (2 × 10 6 cells/well) were incubated with or without the indicated effectors.
Total RNA was extracted with TRIzol (Life Technologies, Inc.). The first strand cDNA synthesis containing 1 g of total RNA was primed with oligo dT. To quantify GM-CSF transcripts, the LightCycler System (Roche Molecular Biochemicals, Indianapolis, IN) was used (28) . PCRs were performed using SYBR Green I master mix and specific primers for mouse GM-CSF and mouse -actin, which were designed as described previously (11, 29) .
Quantitative results of GM-CSF mRNA were normalized for the levels of -actin mRNA. To assess the specificity of the amplified PCR products, after the last cycle, a melting curve analysis was performed.
Western Blot Analysis
Macrophages (2 × 10 6 cells/well in 6-well plate, Nunc) were lysed by the lysis buffer, and centrifuged (20,000 × g at 4°C for 10 min). Supernatants were used as sample proteins. 
Membrane Fraction Extraction
Macrophages (2 × 10 6 cells/well in 6-well plate, Nunc) were suspended in 1 ml of sample preparation buffer (5 mM EDTA, 10 mM ethylene glycol bis (beta-aminoethyl Homogenates were centrifuged at 20,000 × g for 1 h at 4°C. The supernatant was discarded and the precipitates were resuspended in 1 ml of buffer and used as the membrane fractions.
Statistical Analysis
All data were expressed as mean ± SD. Differences between groups were examined for statistical significance using the one-factor ANOVA procedure. A p value less than 0.05 denoted the presence of a statistically significant difference.
Results

Effect of statins on Ox-LDL-induced proliferation and GM-CSF production by macrophages
Consistent with our previous report with simvastatin (19) , cerivastatin as well as simvastatin reduced Ox-LDL-induced [ 3 H]thymidine incorporation in a dose-dependent manner (Fig. 1A) .
Cerivastatin was more potent than simvastatin in inhibiting Ox-LDL-induced macrophage proliferation; the concentration of cerivastatin required for 50% inhibition was 5 nM with a maximum effect observed at 100 nM, whereas 100 nM and 1 M were required, respectively, for simvastatin (Fig. 1A) . Under these conditions, cerivastatin or simvastatin alone had no effect on [ 3 H]thymidine incorporation up to a concentration of 10 M. The cell counting assay also showed that the Ox-LDL-induced increase in cell number was inhibited by 88% or 84% when cells were incubated with 100 nM of cerivastatin or 10 M of simvastatin, respectively (Table 1 ). In the presence of 100 nM cerivastatin or 10 M simvastatin, more than 95% of the macrophages were viable as determined by both the cell counting assay using the trypan blue staining and the release of lactic dehydrogenase (LDH) from these cells (data not shown), indicating that statins at a dose less than 10 M are not cytotoxic to macrophages.
Since we focused on the role of GM-CSF in the Ox-LDL-induced macrophage proliferation (11), we next examined the effect of cerivastatin on Ox-LDL-induced GM-CSF production. Our results showed that GM-CSF production was not affected by pre-treatment with statins both at mRNA (Fig. 1B ) and protein levels (Fig. 1C) . Cerivastatin or simvastatin alone had no effect on the expression of GM-CSF mRNA and protein in these conditions (data not shown).
Effect of statins on GM-CSF-induced macrophage proliferation
GM-CSF-induced [ 3 H]thymidine incorporation was also reduced by both simvastatin and cerivastatin in a dose-dependent manner. Cerivastatin showed stronger effect than simvastatin, and their IC 50 were 80 nM and 700 nM, respectively ( Fig. 2A) . On the other hand, cerivastatin and simvastatin alone had no effect on when macrophages were incubated with either cerivastatin or simvastatin, respectively (Table   1 ). Furthermore, these statins had no effect when used alone ( Table 1) .
Roles of isoprenoids in GM-CSF-induced macrophage proliferation and inhibition by statins
To clarify the roles of metabolites of mevalonate pathway on GM-CSF-induced macrophage proliferation, we examined the effect of mevalonate and its metabolites. As shown in figure   2B , cerivastatin-or simvastatin-mediated inhibition of GM-CSF-induced We previously reported the involvement of p38 MAPK activation in GM-CSF-induced macrophage proliferation (12) . We next examined the effect of statins on GM-CSF-induced ERK1/2 or p38 MAPK phosphorylation. Simvastatin, cerivastatin and isoprenyl transferase inhibitors (FTI and GGTI) had no effect on GM-CSF-induced ERK1/2 phosphorylation ( Fig.   3A and C), but significantly decreased GM-CSF-induced p38 MAPK phosphorylation ( Fig.   3B and D). To determine whether statin-induced inhibition of p38 MAPK phosphorylation was mediated by metabolites of mevalonate pathway, we examined the restorative effect of isoprenyl pyrophostates on the suppression of p38 MAPK phosphorylation by simvastatin. As shown in figure 3E , simvastatin-mediated reduction of p38 MAPK phosphorylation induced by GM-CSF was significantly rescued by co-incubation with FPP or GGPP.
Effect of statins on membrane localization of Ras and RhoA
To determine whether statins regulate the activity of small G proteins, which are upstream components of MAPK cascades, in macrophages, we next examined the membrane localization of Ras and RhoA. Stimulation with GM-CSF (15 pM) increased the level of membrane-bound Ras (Fig. 4A) and RhoA (Fig. 4B) , and simvastatin significantly prevented GM-CSF-induced Ras and RhoA membrane localization without affecting the total amount of these proteins in macrophages ( Fig. 4A and B) . The inhibitory effect of simvastatin on Ras membrane localization was completely reversed by FPP and partially reversed by GGPP (Fig.   4A ). In contrast, co-treatment with GGPP completely reversed the inhibitory effect of simvastatin on RhoA membrane localization, whereas only partially with FPP (Fig. 4A) .
Involvement of small G proteins in GM-CSF-induced macrophage proliferation through the activation of p38 MAPK
the activation of MAPKs in the signaling pathways of macrophage proliferation induced by GM-CSF. For this purpose, we introduced adenoviruses that expressed dominant negative forms of Ras and Rho. GM-CSF-induced ERK1/2 phosphorylation was increased in the cells infected with dominant negative form of Rho, but was significantly decreased in the cells infected with dominant negative form of Ras (Fig. 4C) . On the other hand, GM-CSF-induced p38 MAPK phosphorylation was significantly decreased in the cells infected with dominant negative form of Ras or Rho, with much stronger effect of DN-Rho (Fig. 4D ). Adenoviral control vector has no effect on ERK1/2 phosphorylation or p38 MAPK phosphorylation ( 
Discussion
Macrophage proliferation in atherosclerotic lesions has been demonstrated by several groups (1-3), and the proliferation was also reported to be reduced by statin treatment (6) . Regarding the effect of statins, we demonstrated in a previous study that Ox-LDL-induced macrophage proliferation was inhibited by simvastatin and pravastatin (19) . In the present study, we further demonstrated the impacts of Ras and Rho on Ox-LDL-induced macrophage proliferation, and provided evidences that statins inhibit the proliferation by suppressing p38
MAPK through the inhibition of Ras and Rho in the signaling pathways downstream of GM-CSF receptor, without affecting GM-CSF production.
Based on our previous studies, Ox-LDL-induced GM-CSF production is mainly involved in macrophage proliferation (11) . Thus, the mechanisms of Ox-LDL-induced macrophage proliferation can be divided into two parts; (i) intracellular signaling pathway before GM-CSF release, and (ii) proliferation signaling pathway through GM-CSF receptor.
Moreover, we reported that ERK1/2 and p38 MAPK play pivotal role in each stage of signaling pathways (12) . In the present study, although cerivastatin as well as simvastatin inhibited the Ox-LDL-induced macrophage proliferation, these two statins had no effect on GM-CSF production either at mRNA or protein levels. On the other hand, these statins showed significant inhibition on recombinant GM-CSF-induced p38 MAPK phosphorylation and macrophage proliferation. Therefore, statins inhibited macrophage proliferation by altering the signals from GM-CSF receptor to p38 MAPK.
We demonstrated in the present study that the inhibitory effect of statins on Ox-LDL-or GM-CSF-induced macrophage proliferation was prevented completely by mevalonate, but not by squalene. In addition, we found that GGTI showed more potent inhibitory effect than FTI on Ox-LDL-or GM-CSF-induced macrophage proliferation. The activation of ERK is widely known to be mediated through the Ras-Raf-MEK cascade (39). In the present study, it was of note that simvastatin completely inhibited GM-CSF-induced membrane translocation of Ras, but had only a small effect on the phosphorylation of ERK. These results suggest that in macrophages, GM-CSF-induced ERK1/2 activation is mediated through some other signaling pathways than Ras-Raf-MEK. It is generally accepted that the targets of protein farnesylation and geranylgeranylation are members of Ras and Rho protein family, respectively. However, the effect of simvastatin on Ras membrane translocation was reversed by co-incubation with not only FPP but also with GGPP, although the latter effect was partial. This is possibly explained by alternative modification of small G proteins. Indeed, K-Ras is normally farnesylated but it can be alternatively geranylgeranylated in the absence of FPP (40). Similarly, RhoB can be either geranylgeranylated or farnesylated by geranylgeranyl transferase I (41, 42). Thus, it is suggested that Ras, which is usually modified by FPP, was prenylated by GGPP under our experimental conditions. However, our data also indicated that farnesyl transferase inhibitor and dominant negative Ras still suppressed p38 MAPK phosphorylation and macrophage proliferation. These results suggest that even it is only partial, Ras mediates the GM-CSF-induced p38 MAPK phosphorylation, which results in macrophage proliferation.
Recent studies reported that small G-protein Rho and its effector, Rho kinase/ROK/ROCK is involved in accelerating atherosclerotic process. Indeed, Miyata et al. 
